MFDS
- Marketing authorisation holder: ELAN PHARM
- Status: likely_approved
🇰🇷 Myobloc in South Korea
Myobloc (RIMABOTULINUMTOXINB) regulatory status in South Korea.
Marketing authorisation
Myobloc in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Myobloc approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Myobloc in South Korea?
ELAN PHARM holds the South Korean marketing authorisation.